Literature DB >> 24878411

The modified Lapidus fusion.

Timo Schmid1, Fabian Krause2.   

Abstract

Due to its proximal correction site and long lever arm, the Lapidus fusion, modified or not, is a powerful technique to correct hallux valgus deformities. The disadvantages are a high complication rate and a long postoperative rehabilitation period. It is only performed in 5% to 10% of all hallux valgus deformity corrections but remains, however, an important procedure, especially in moderate to severe deformities with intermetatarsal angles more than 14°, hypermobility of the first ray, arthritis of the first tarsometatarsal joint, and recurrent deformities. This article provides an overview of the procedure with special focus on the surgical technique.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hallux valgus; Metatarsocuneiform fusion; Modified Lapidus procedure; Technique

Mesh:

Year:  2014        PMID: 24878411     DOI: 10.1016/j.fcl.2014.02.005

Source DB:  PubMed          Journal:  Foot Ankle Clin        ISSN: 1083-7515            Impact factor:   1.653


  3 in total

Review 1.  [Lapidus arthrodesis].

Authors:  C Plaaß; L Claaßen; S Ettinger; K Daniilidis; C Stukenborg-Colsman
Journal:  Orthopade       Date:  2017-05       Impact factor: 1.087

2.  Early results and complication rate of the LapiCotton procedure in the treatment of medial longitudinal arch collapse: a prospective cohort study.

Authors:  Cesar de Cesar Netto; Amanda Ehret; Jennifer Walt; Rogerio Marcio Kajimura Chinelati; Kevin Dibbern; Kepler Alencar Mendes de Carvalho; Tutku Erim Tazegul; Matthieu Lalevee; Nacime Salomão Barbachan Mansur
Journal:  Arch Orthop Trauma Surg       Date:  2022-03-21       Impact factor: 3.067

3.  Cohort Comparison of Radiographic Correction and Complications Between Minimal Invasive and Open Lapidus Procedures for Hallux Valgus.

Authors:  Diogo Vieira Cardoso; Andrea Veljkovic; Kevin Wing; Murray Penner; Oliver Gagne; Alastair Younger
Journal:  Foot Ankle Int       Date:  2022-07-26       Impact factor: 3.569

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.